The FDA approved Eli Lilly’s Omvoh in Crohn’s disease, the company announced Wednesday, handing the drug its second ...

The Drug Enforcement Administration has issued a long-awaited proposed rule that would create a permanent process for ...

The Department of Health and Human Services says Vertex is 'grasping at straws' in a lawsuit challenging the agency’s ...

HER2 shows promise in Phase 2b osteosarcoma trial, with improved event-free survival at 12 months; company plans to pursue ...

Johnson & Johnson, AstraZeneca and Pfizer leaders reiterated during the JP Morgan Healthcare Conference that the federal ...

Hinge Bio raises $30M Series A for lupus drug; Keros halts trial dosing; Inflammasome reports eye treatment data; J&J files bladder cancer therapy; Verastem licenses KRAS drug ...

Samsung Biologics plans sixth facility amid growth, prepares to open Plant 5 in April, expands ADC services, and adds ...

Eli Lilly expects to miss its recent revenue estimate for 2024 by about $400 million, according to a preliminary report.